Chris Bodnar leaves CBRE to co-found and lead Denver-based Prescriptive Capital
By John B. Mugford
Chris Bodnar is teaming with Brue Baukol Capital Partners to help the firm’s investors diversify into healthcare and life sciences real estate. (Photo courtesy of Chris Bodnar)
For more than a decade now, Christopher R. “Chris” Bodnar has been one of the most prolific, best-known medical office building (MOB) sales brokers in the industry.
During his tenure at CBRE Group Inc. (NYSE: CBRE), where he started the U.S. Healthcare and Life Sciences Capital Markets team in 2007 and then teamed with Lee Asher as the group’s co-vice chairmen in 2011, Mr. Bodnar has been involved in HRE facility sales totaling more than 50 million square feet and $20 billion.
In breaking news, Mr. Bodnar’s days as an HRE facilities investment sales broker have come to end, however, as he tells HREI in an exclusive interview that he is leaving CBRE in order to launch a new venture on the principal, or ownership, side of the business.
Mr. Bodnar is the CEO and co-founder of the newly formed and Denver-based Prescriptive Capital. He formed the firm in a joint venture (JV) partnership with Denver-based Brue Baukol Capital Partners, a private equity real estate investment firm that since its formation in 2011 has acquired and developed more than $3 billion worth of commercial real estate, multifamily properties and operating businesses. Mr. Asher will continue to lead the CBRE team.
Prospective Capital is focused on acquiring and owning MOBs, life sciences facilities and senior living communities. Mr. Bodnar is the co-founder along with Chad and Geoff Brue of Brue Baukol Capital Partners.
“While there is a lot institutional capital seeking opportunities in these alternative sectors, we’ve created a unique platform where we can provide very flexible solutions for our partners,” Mr. Bodnar said in a news release. “Our goal is to be an alternative to traditional institutional capital – allowing our operating partners to run their business autonomously while providing them the opportunity to leverage our team’s relationships and experience.”
In commenting on the formation of the new firm, Chad Brue, CEO and founder of Brue Baukol Capital Partners, said: “Brue Baukol Capital Partners has enjoyed great success investing in traditional real estate asset classes. However, our investors continue to seek ways to diversify their portfolio with alternative real estate assets, necessitating a platform that’s solely focused on these nuanced sectors. Chris is a proven leader in healthcare and life sciences, and we’re excited to partner with him under the Prescriptive Capital brand.”
In order to provide further details on Prospective Capital, HREI posed some questions to Mr. Bodnar.
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
